The Use of Multiparametric Magnetic Resonance Imaging (mpMRI) in the Detection, Evaluation, and Surveillance of Clinically Significant Prostate Cancer (csPCa)-Reference-Cited by-同舟云学术

The Use of Multiparametric Magnetic Resonance Imaging (mpMRI) in the Detection, Evaluation, and Surveillance of Clinically Significant Prostate Cancer (csPCa)

Published:2019-09-02 Issue:10 Volume:20 Page:
ISSN:1527-2737
Container-title:Current Urology Reports
language:en
Short-container-title:Curr Urol Rep

Author:

Patel Parth,Wang Shu,Siddiqui Mohummad Minhaj

Publisher

Springer Science and Business Media LLC

Subject

Urology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11934-019-0926-0.pdf

Reference36 articles.

1. Siegel RL, Miller KD. 2019. CA Cancer J Clin 2019;69:7–34, Cancer statistics, 2019.

2. Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Fütterer JJ, Gill IS, et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an international working group. Eur Urol. 2013;64:544–52.

3. Imaging P. Pi-Rads. https://www.acr.org/-/media/ACR/Files/RADS/Pi-RADS/PIRADS-V2.pdf [Internet]. 2015; Available from: https://www.acr.org/-/media/ACR/Files/RADS/Pi-RADS/PIRADS-V2.pdf

4. Kundra V, Silverman PM, Matin SF, Choi H. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer. Am J Roentgenol. 2007.

5. Tooker GM, Truong H, Pinto PA, Siddiqui MM. National survey of patterns employing targeted MRI/US guided prostate biopsy in the diagnosis and staging of prostate cancer. Curr Urol. 2019;21201:97–103.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 68Ga-PSMA PET/CT-based multivariate model for highly accurate and noninvasive diagnosis of clinically significant prostate cancer in the PSA gray zone;Cancer Imaging;2023-09-04

2. Intravoxel incoherent motion predicts positive surgical margins and Gleason score upgrading after radical prostatectomy for prostate cancer;La radiologia medica;2023-06-05

3. Traditional and novel imaging modalities for advanced prostate cancer: A critical review;Urology Annals;2023

4. An independent practice validation of the Prostate Imaging Reporting and Data System version 2 scoring system and the introduction of PDP (prostate-specific antigen density × PI-RADSv2) score to assist with further risk assessment;Current Urology;2022-08-31

5. Specified iron oxide nanoparticles by PSMA-11 as a promising nanomolecular imaging probe for early detection of prostate cancer;Applied Nanoscience;2022-06-17